<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR35">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Murray</surname>
    <given-names>ME</given-names>
   </name>
   <name>
    <surname>Lowe</surname>
    <given-names>VJ</given-names>
   </name>
   <name>
    <surname>Graff-Radford</surname>
    <given-names>NR</given-names>
   </name>
   <name>
    <surname>Liesinger</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Cannon</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Przybelski</surname>
    <given-names>SA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum</article-title>
  <source>Brain</source>
  <year>2015</year>
  <volume>138</volume>
  <fpage>1370</fpage>
  <lpage>1381</lpage>
  <pub-id pub-id-type="doi">10.1093/brain/awv050</pub-id>
  <?supplied-pmid 25805643?>
  <pub-id pub-id-type="pmid">25805643</pub-id>
 </element-citation>
</ref>
